Monocyte microRNA signatures in late-onset neonatal sepsis
- 1University of Patras, School of Medicine, University General Hospital of Patras, Department of Pediatrics
Abstract
Purpose: Neonatal late-onset sepsis (LOS) remains a major cause of neonatal morbidity and its non-specific presentation challenges early diagnosis. MicroRNAs (miRNAs) are promising biomarkers, but unbiased next-generation sequencing (NGS) of monocyte-specific miRNA has not been applied to neonatal LOS. We aimed to identify the monocyte-specific miRNA expression profile in neonatal LOS and its associations with the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). Methods: In a prospective study at the University General Hospital of Patras, 30 samples from 15 neonates with LOS and 8 healthy controls were analyzed. Monocyte miRNA expression was characterized by NGS pre and post antimicrobial therapy in cases and controls. Predicted target genes of the major candidate miRNAs were evaluated by RT-qPCR in an independent cohort. Clinical severity was assessed using NLR and SII. Results: Hsa-miR-6743-3p was significantly upregulated on day 0 and returned to control levels by day 2. Four additional miRNAs (hsa-miR-7108-5p, hsa-miR-3940-5p, hsa-miR-6851-3p and hsa-miR-1909-3p) exhibited a consistent trend toward upregulation in acute LOS. NLR, but not SII, was significantly elevated at diagnosis and showed excellent diagnostic performance (AUC 0.958), normalizing by day 2. Hsa-miR-7108-5p correlated positively with NLR on day 0. In the RT-qPCR cohort, its predicted target DRAM2, was reduced on day 0 and partially recovered by day 2. Conclusion: Monocyte miRNA profiling identified transient alterations in neonatal LOS that parallel clinical severity, while NLR showed high discriminatory performance. These exploratory findings warrant validation in larger cohorts to verify monocyte miRNAs as potential biomarkers of neonatal LOS.
Related
- White blood cell and neutrophil trends in likely early-onset neonatal sepsis: a sex-stratified analysis before and after antibiotic therapy
- Maternal Vaginal Pathogenic Bacterial Colonization and Early-Onset Neonatal Sepsis in Mwanza City, Tanzania: A Prospective Cohort Study.
- Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis
- Serum proteomics in newborns reveals a multi-pathway molecular panel for neonatal sepsis, encompassing pathogen sensing, leukocyte recruitment, and endothelial injury.
- The prevalence of neonatal sepsis caused by gram-negative bacteria and their antibiotic resistance patterns in Pakistan: a systematic review and meta-analysis
BibTeX
@misc{gkouti2026monocyte,
title = {{Monocyte microRNA signatures in late-onset neonatal sepsis}},
author = {E. Gkouti and A. Kouvela and E. Papachatzi and M. Apostolidi and G. Dimitriou and V. Stamatopoulou and D. Gkentzi},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.759337},
url = {https://www.biorxiv.org/content/10.64898/2026.10.15.759337v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Monocyte microRNA signatures in late-onset neonatal sepsis
AU - E. Gkouti
AU - A. Kouvela
AU - E. Papachatzi
AU - M. Apostolidi
AU - G. Dimitriou
AU - V. Stamatopoulou
AU - D. Gkentzi
PY - 2026
DA - 2026/10/15
PB - bioRxiv
DO - 10.64898/2026.10.15.759337
UR - https://www.biorxiv.org/content/10.64898/2026.10.15.759337v1
AB - Purpose: Neonatal late-onset sepsis (LOS) remains a major cause of neonatal morbidity and its non-specific presentation challenges early diagnosis. MicroRNAs (miRNAs) are promising biomarkers, but unbiased next-generation sequencing (NGS) of monocyte-specific miRNA has not been applied to neonatal LOS. We aimed to identify the monocyte-specific miRNA expression profile in neonatal LOS and its associations with the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). Methods: In a prospective study at the University General Hospital of Patras, 30 samples from 15 neonates with LOS and 8 healthy controls were analyzed. Monocyte miRNA expression was characterized by NGS pre and post antimicrobial therapy in cases and controls. Predicted target genes of the major candidate miRNAs were evaluated by RT-qPCR in an independent cohort. Clinical severity was assessed using NLR and SII. Results: Hsa-miR-6743-3p was significantly upregulated on day 0 and returned to control levels by day 2. Four additional miRNAs (hsa-miR-7108-5p, hsa-miR-3940-5p, hsa-miR-6851-3p and hsa-miR-1909-3p) exhibited a consistent trend toward upregulation in acute LOS. NLR, but not SII, was significantly elevated at diagnosis and showed excellent diagnostic performance (AUC 0.958), normalizing by day 2. Hsa-miR-7108-5p correlated positively with NLR on day 0. In the RT-qPCR cohort, its predicted target DRAM2, was reduced on day 0 and partially recovered by day 2. Conclusion: Monocyte miRNA profiling identified transient alterations in neonatal LOS that parallel clinical severity, while NLR showed high discriminatory performance. These exploratory findings warrant validation in larger cohorts to verify monocyte miRNAs as potential biomarkers of neonatal LOS.
ER -